Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews · Dementia and Cognitive Improvement

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Rosiglitazone plus metformin vs glibenclamide (glyburide) plus metformin

Cognitive function · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rosiglitazone plus metformin vs glibenclamide (glyburide) plus metformin

Incidence of MCI · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rosiglitazone plus metformin vs glibenclamide (glyburide) plus metformin

Incidence of dementia · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rosiglitazone plus metformin vs glibenclamide (glyburide) plus metformin

Adverse events (Hypoglycaemia) · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rosiglitazone plus metformin vs glibenclamide (glyburide) plus metformin

All‐cause mortality · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found